FORMULATION AND EVALUATION OF FAST DISSOLVING TABLETS OF VALDECOXIB
Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2018, Vol 7, Issue 6
Abstract
Valdecoxib is a selective COX- II inhibitor with anti – inflammatory, analgesic and antipyretic properties. The poor aqueous solubility of the drug leads to variable dissolution rates. In the present study an attempt has been made to prepare fast dissolving tablets of Valdecoxib in the oral cavity with enhanced dissolution rate. The fast dissolving tablets of Valdecoxib was prepared with some carriers (polymers) and super disintegrants such as Polyvinyl Pyrrolidone (PVP), Sodium Carboxy Methyl Cellulose (SCMC), Crospovidone NF and β – Cyclodextrin. The above mentioned all carriers and superdisintegrants were taken in different proportions of 5, 10, and 15%. All the formulations of the fast dissolving tablets of Valdecoxib were prepared by direct compression technique. The blend was examined for Angle of repose, Bulk density, Compressibility index and Hausner’s ratio. The prepared tablets were evaluated for hardness, drug content uniformity, friability, disintegration time and dissolution rate. An effective pleasant testing formulation released 99.88% drug within 10 minutes. The prepared formulations drug release was found to be comparable with the marketed dispersible tablets. Keywords: Fast dissolving tablets, Super-disintegrants, Valdecoxib, Crosspovidone, Sodium Carboxy Methyl Cellulose.
Authors and Affiliations
K Kareemuddin Ansari
Keywords
Related Articles
- EP ID EP487318
- DOI -
- Views 108
- Downloads 0
RELATION OF ANTIOXIDANT STATUS AND LIPOPROTEIN (a) LEVEL IN MYOCARDIAL INFARCTION PATIENTS : A CLINICAL STUDY TO EVALUATE THE ANTIOXIDANT/ LIPOPROTEIN (a) RATIO AS A NOVEL PARAMETER TO INDICATE CARDIOVASCULAR ACCIDENT
Lipoprotein (a), a prominent marker of cardiovascular accident, was first described by Berg in 1963(3). Lipoprotein (a) [Lp(a)] has been considered as one of the distinguished signature in myocardial infarction and for...
ANTI-HYPERTENSIVE DRUGS USED DURING PREGNANCY
Hypertension is a major cause of maternal and fetal mortality during pregnancy. Estimated to cause complications in around 15% pregnancies, hypertension is the most commonly encountered medical complication during pregna...
ESTIMATION OF THE INCIDENCE OF INTRAOPERATIVE AWARENESS AND RECALL IN WAD MEDANI TEACHING HOSPITAL - SUDAN
The study was having been conducted in Wad Medani Teaching Hospital from March to September 2016. The objective of the study was to estimate the incidence of awareness under general anesthesia in Wad Medani Teaching Hosp...
EFFICACY OF DIPEPTIDYL PEPTIDASE-4 INHIBITOR WITH ZINC AND CHROMIUM PICOLINATE IN PATIENTS OF TYPE-II DIABETES MELLITUS
In the present study, we have evaluated the effect of Zinc (Zn) and Chromium picolinate (CrPic) supplementation with sitagliptin in Type-II DM patients. A randomized controlled trial was conducted on 600 patients sufferi...
Evaluation of quality of life in hemodialysis patients and measurement of clinical outcomes
End stage renal disease is the final stage of chronic kidney disease in which the kidneys longer function well enough to meet needs of life. The treatments for ESRD are dialysis or kidney transplant. Hemodialysis (HD) is...